Charles Schwab Investment Management Inc Aura Biosciences, Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 134,744 shares of AURA stock, worth $1.22 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
134,744
Previous 106,244
26.83%
Holding current value
$1.22 Million
Previous $834,000
22.06%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding AURA
# of Institutions
75Shares Held
40.4MCall Options Held
800Put Options Held
1.8K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$62.5 Million0.4% of portfolio
-
Eventide Asset Management, LLC Boston, MA5.8MShares$52.4 Million0.77% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.89MShares$44.1 Million0.07% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$27.5 Million8.2% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$27.1 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $264M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...